We are live on ! Find out more
PTCT icon

PTC Therapeutics
PTCT

115 hedge funds and large institutions have $408M invested in PTC Therapeutics in 2016 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 39 increasing their positions, 36 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

102% more capital invested

Capital invested by funds: $202M → $408M (+$206M)

59% more call options, than puts

Call options by funds: $14.6M | Put options by funds: $9.19M

8% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 36

3% less funds holding

Funds holding: 118 → 115 (-3)

11% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 19

Holders
115
Holders Change
-3
Holders Change %
-2.54%
% of All Funds
3.07%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
17
Increased
39
Reduced
36
Closed
19
Calls
$14.6M
Puts
$9.19M
Net Calls
+$5.39M
Net Calls Change
+$3.14M

Top Buyers

Rank Fund Capital Flow
1
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$5.87M
2
Deutsche Bank
Deutsche Bank
Germany
+$4.32M
3
CCM
Camber Capital Management
Massachusetts
+$4.06M
4
Renaissance Technologies
Renaissance Technologies
New York
+$3.66M
5
BIM
Bogle Investment Management
Massachusetts
+$3.6M

Top Sellers

Rank Fund Capital Flow
1
PAMU
Pictet Asset Management (UK)
United Kingdom
-$10.8M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$7.2M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$3.91M
4
Jennison Associates
Jennison Associates
New York
-$3.13M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$2.46M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
26
Fidelity Investments
Massachusetts
$3.51M -$7.2M -885,723 -78%
Millennium Management
27
Millennium Management
New York
$3.43M +$1.57M +192,535 +370%
Geode Capital Management
28
Geode Capital Management
Massachusetts
$3.21M +$28K +3,442 +2%
QI
29
QS Investors
New York
$3.16M +$50.1K +6,161 +3%
PI
30
Putnam Investments
Massachusetts
$3.06M -$15.4K -1,900 -0.9%
PCM
31
Prelude Capital Management
New York
$3.03M +$1.68M +207,171 +2,354%
SDIC
32
South Dakota Investment Council
South Dakota
$2.79M – – –
BG
33
BlackRock Group
United Kingdom
$2.78M -$32.1K -3,947 -2%
BIM
34
BlackRock Investment Management
Delaware
$2.54M -$15K -1,846 -1%
Bank of New York Mellon
35
Bank of New York Mellon
New York
$2.34M +$139K +17,076 +11%
PP
36
PDT Partners
New York
$2.33M +$1.35M +166,100 New
CWG
37
C WorldWide Group
Denmark
$2.25M +$789K +97,000 +152%
Goldman Sachs
38
Goldman Sachs
New York
$2.1M +$655K +80,576 +117%
Simplex Trading
39
Simplex Trading
Illinois
$1.68M +$977K +120,210 New
Norges Bank
40
Norges Bank
Norway
$1.68M +$733K +90,181 +256%
Charles Schwab
41
Charles Schwab
California
$1.58M +$437K +53,740 +91%
JG
42
Jefferies Group
New York
$1.4M +$813K +100,000 New
MCM
43
Moore Capital Management
New York
$1.4M +$813K +100,000 New
Fisher Asset Management
44
Fisher Asset Management
Washington
$1.26M – – –
Barclays
45
Barclays
United Kingdom
$1.25M +$604K +74,352 +502%
DC
46
Davenport & Co
Virginia
$1.15M – – –
EAM
47
EverPoint Asset Management
Connecticut
$1.05M +$610K +75,000 New
California State Teachers Retirement System (CalSTRS)
48
California State Teachers Retirement System (CalSTRS)
California
$984K +$4.07K +500 +0.7%
AllianceBernstein
49
AllianceBernstein
Tennessee
$976K -$48.8K -6,000 -8%
EGA
50
Eagle Global Advisors
Texas
$949K +$316K +38,880 +135%
1
2
3 4 5

PTCT Hedge Fund Activity: Q3 2016 in Review

115 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in PTC Therapeutics (PTCT) for Q3 2016, worth a combined $408M — up 102% from $202M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of PTCT and 17 opened new positions — a net loss of 2 holders — while 36 trimmed existing stakes and 39 added.

The largest buyer was D.E. Shaw & Co, adding an estimated $5.87M. The largest seller was Pictet Asset Management (UK), exiting entirely with an estimated $10.8M sold.

  • 115 institutional investors held PTC Therapeutics (PTCT) as of Q3 2016, down from 118 in Q2 2016.
  • Funds reported $408M of PTC Therapeutics stock for Q3 2016, up 102% quarter-over-quarter.
  • 17 funds opened new PTC Therapeutics positions in Q3 2016 and 19 closed out, a net change of -2 holders.
  • The largest PTC Therapeutics buyer in Q3 2016 was D.E. Shaw & Co, an estimated $5.87M added.
  • The largest PTC Therapeutics seller in Q3 2016 was Pictet Asset Management (UK), an estimated $10.8M sold.

Based on aggregated 13F filings for Q3 2016.